Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

Cryotherapy 7 resiquimod 6 Cantharidin 4 Cholecalciferol 3 PRA1 protein, Candida albicans 2 N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2 Measles-Mumps-Rubella Vaccine 2 2-Propanol 2 plerixafor 1 methyl 5-aminolevulinate 1 lactic acid, salicylic acid drug combination 1 green tea extract polyphenone E 1 gluconic acid 1 ammonium trichloro(dioxoethylene-O,O'-)tellurate 1 VP-102 1 Tuberculin 1 Trichloroacetic Acid 1 Sugars 1 Starch 1 Photochemotherapy 1 Nitric Oxide 1 Mass Screening 1 Maltose 1 Lasers, Solid-State 1 Lasers 1 Interferon-alpha 1 Imiquimod 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Granulocyte Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Warts × Exercise × Clear all

NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed

502 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡